Fig. 5From: Comparison of cisplatin-induced anti-tumor response in CT26 syngeneic tumors of three BALB/c substrainsExpression analysis of p53 and p27 proteins. Expression levels of p53 and p27 proteins were determined in CT26 tumors of the three cisplatin-treated BALB/c substrains, using specific antibodies and an imaging densitometer. The levels of each protein are presented relative to the intensity of actin. Two to three tumors per group were used to prepare the total tumor homogenate, and Western blot analysis was assayed in duplicate for each sample. The data are reported as the means ± SD. *, p < 0.05 relative to the No treated group. #, p < 0.05 compared to the Vehicle treated groupBack to article page